Abstract:Background: Disease extent varies in UC from proctitis (E1) to left-sided colitis (E2) and pancolitis (E3).When the extent of UC is limited (E1/E2) there is a sharp demarcation between macroscopically involved and uninvolved areas, which remains unexplained.Since 25% of patients with limited UC extend over time, we assessed molecularly the mechanisms defining the anatomic delineation between affected and unaffected colon.Method: We performed RNA-seq analysis on gut biopsies from UC patients and characterized the inflammation signature at and proximal to the endoscopic demarcation of disease.We collected biopsies from endoscopically involved rectum, sigmoid and left colon of 37, 12 and 9 UC patients, respectively.From each of these patients we also sampled uninvolved areas, either directly adjacent to the inflamed site or more proximal.The resulting 148 paired biopsies were then 'ordered' by inflammation status and gut location and a 'distance' from inflammation was assigned for each biopsy.The distance from the first adjacent region to the inflamed biopsy was defined as D=1, for example inflamed rectum and uninflamed sigmoid.A D=2, was assigned if the adjacent biopsy was 2 regions away from the inflamed biopsy (inflamed rectum and uninflamed left colon) and so on up to D=5.We modeled the gene expression changes over all the distances from inflammation.To account for molecular differences due to region, biopsies from non-IBD control patients matched for regions were used (Fig1).Results:Two striking patterns of molecular expression were observed.One included genes which progressively changed in expression as the distance from the site of inflammation increased ('slope geneset').The second included genes that abruptly changed in expression at the first adjacent region to the inflamed biopsy and did not change further ('wall geneset').Slope genes decreasing in expression included acute and chronic inflammatory processes such as IFNg, IL6 and oncostatin-M suggesting the reach of inflammation was further than observed by endoscopy.However, a subset of inflammatory genes as well as integrins and adhesion molecules had sharply decreased expression at the adjacent uninflamed region (wall genes: IL23A, IL22, TNF and IL10) suggesting these may be important for modulating the progression of extensive inflammation.Upregulated slope genes included solute carrier and homeobox genes while upregulated wall genes included glucoronidation and fatty acid binding proteins, suggesting altered gut function (Fig2a).Conclusion:We reveal a complex molecular pattern emanating from the 'visible' line of disease demarcation, of both progressive and acute changes (Fig2b), helping to understand for the first time its origin and potentially provide biomarkers of UC extension.

Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis

Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn's disease

Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients

Digital Spatial Profiling Reveals Functional Shift of Enterochromaffin Cell in Patients with Ulcerative Colitis.

Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC

An epigenetic basis for sustained inflammatory epithelial progenitor cell states in Crohn's disease

Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease

Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies

Transcriptome Profiling of Human Ulcerative Colitis Mucosa Reveals Altered Expression of Pathways Enriched in Genetic Susceptibility Loci.

P004 Microbiota, not host origin drives ex vivo epithelial response in ulcerative colitis patients and non-IBD controls

P107 Comparing the Colonic Tissue Proteome of Active and Inactive Ulcerative Colitis

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis

Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights

Exposure of Colon-Derived Epithelial Monolayers to Fecal Luminal Factors from Patients with Colon Cancer and Ulcerative Colitis Results in Distinct Gene Expression Patterns

A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon Epithelium by Single-Cell Transcriptomics

Single-cell analysis of colonic epithelium reveals unexpected shifts in cellular composition and molecular phenotype in treatment-naïve adult Crohn’s disease

Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis

Colonic epithelial cell diversity in health and inflammatory bowel disease

P078 Inflammatory transcriptomic signatures and cell type compositions in colonic mucosa of ulcerative colitis

Tu1802 - Disease Demarcation in Ulcerative Colitis is Associated with Different Patterns of Gene Expression

Molecular Activity of Inflammation and Epithelial-Mesenchymal Transition in the Microenvironment of Ulcerative Colitis